Effects of Interleukin-13 and Montelukast on the Expression of Zonula Occludens-1 in Human Podocytes
Open Access
- 1 January 2015
- journal article
- Published by XMLink in Yonsei Medical Journal
- Vol. 56 (2) , 426-432
Abstract
Park SJ, et al. Yonsei Med J. 2015 Mar;56(2):426-432. https://doi.org/10.3349/ymj.2015.56.2.426Keywords
Funding Information
- National Research Foundation of Korea (2011-0013789)
This publication has 39 references indexed in Scilit:
- Cough, asthma, and cysteinyl-leukotrienesPulmonary Pharmacology & Therapeutics, 2013
- Cell Biology and Pathology of PodocytesAnnual Review of Physiology, 2012
- ZO-1 Stabilizes the Tight Junction Solute Barrier through Coupling to the Perijunctional CytoskeletonMolecular Biology of the Cell, 2009
- Adherens and tight junctions: Structure, function and connections to the actin cytoskeletonBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change diseaseNephrology Dialysis Transplantation, 2005
- Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epitheliumPediatric Nephrology, 2004
- Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndromePediatric Nephrology, 2004
- The role of podocytes in glomerular pathobiologyClinical and Experimental Nephrology, 2003
- Signalling to and from tight junctionsNature Reviews Molecular Cell Biology, 2003
- PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membraneJournal of Clinical Investigation, 1999